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Neurotrophins (NTs) are a family of growth/survival factors with well-established 
functions in the nervous system. In the last decade, novel biological actions, from onco-
genicity to inﬂ ammation, have been attributed to these factors. In particular, Nerve 
Growth Factor (NGF) acts through two diff erent classes of receptors: the high affi  nity 
transducing TrKA receptor, associated to proliferation/survival, and the low affi  nity 
p75 receptor that, depending on its cross talk with TrKA, induces either apoptosis or 
survival. Recently, NGF and its receptors have been detected in healthy pulmonary tis-
sues and seem to be involved in pulmonary inﬂ ammatory diseases. Since the expres-
sion of these NGF receptors in circulating monocytes is controversial, our initial aim 
was to investigate the role of these receptors both in pulmonary tissues and in periph-
eral blood monocytes of patients with Chronic Obstructive Pulmonary Disease (COPD). 
We therefore analyzed 38 healthy control subjects divided in two groups based on their 
smoking status. Serendipitously, the data obtained in these two control groups may 
have a value of their own, with potential implications in preventive medicine.
We show here that in healthy subjects, smoking induces an early increase in p75 
expression in monocytes, while TrKA seems unaff ected. Furthermore, our control 
subjects could be divided in three subsets according to the constitutive TrKA expres-
sion in monocytes: TrKA-negatives, -intermediates (up to 50%) or -high (> 50%), inde-
pendently on their smoking status. Since TrKA activation promotes inﬂ ammation, we 
hypothesize that subjects with high-TrKA monocytes could be more prone to pulmo-
nary inﬂ ammatory diseases, such as COPD. In fact, all 28 COPD patients in our series 
belonged to the high-TrKA subset, while all long term heavy smokers with no evi-
dence of pneumologic diseases belonged to TrKA-negative subset.
In conclusion, our data support the hypothesis that, since TrKA expression pro-
motes survival, elevated levels of TrKA-positive monocytes may render subjects 
more prone to long term inﬂ ammatory diseases (e.g., COPD). Moreover, in patients 
constitutively expressing high levels of TrKA in monocytes, the smoking-dependent 
increase in p75 may in turn further extend monocytes survival, contributing to a 
chronic inﬂ ammation. Furthermore, the early increase in p75 expression in monocytes 
following smoking may support the hypothesis that p75 determination might repre-
sent a novel marker for passive smoking.
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